Human bodies age due to various factors such as energy and food availability and to some extent; stressing factors in their environment. Mikhail Blagosklonny is one of the oncologists who are committed to the research of cancer and aging. He confirms that Target Of Rapamycin (TOR) plays a role in the aging process of human beings. Research has shown that TOR is a regulating agent in the aging of organisms both small and big. This is because TOR determines how cellular systems coordinate growth in response to the changes in their immediate environment. Blagosklonny’s recent hypothesis in TOR suggests that, ageing can be treated with drugs that contain Rapamycin that is used in treatment of cancer. He is also among the oncology doctors committed in finding a cure for cancer.
With a master’s degree in internal medicine and a Ph.D. in cardiology and experimental medicine, Mikhail Blagosklonny teaches at Roswell Park, a cancer institute. He takes interest in oncology and anti-aging. He has lectured in other institutions and was the associate professor of medicine at New York medical college from 2002. He was later appointed as the senior scientist at Ordway Research Institute in New York where he worked before he moved to Roswell Park. Visit ResearchGate.Net to know more about Mikhail’s latest work.
Blagosklonny has published close 270 articles in peer reviewed journals. He also edits article, journals and papers related to cancer treatment and aging. He is member of the Cell Death & Differentiation’s editorial board and holds an editorial position for the Cancer Biology & Therapy. He is currently the editor in chief of Cell Cycle, Aging and Oncotarget which he is famous for editing. At Oncotarget, he mostly edits the researches and publications on cancer therapy, diagnosis and treatment. It also accepts articles in other areas such as Cell Biology, Neuroscience, Endocrinology, Metabolism, Cardiology and Pharmacology. Aging is a medical journal that covers the researches and progress in the field of molecular mechanics of senescence and aging. Most of these journals like Octotarget have a free- access and publishes papers online weekly with the main aim as to help people contribute to the progress of science discoveries. It is a contribution targeted at attaining a disease free society one day. Follow Mikhail on Loop
Read more: http://www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899